Prince George’s will use DNA registries to solve cold cases through new DOJ grant
By Katie Mettler,
Washington Post
| 11. 19. 2020
Prince George’s County is one of 10 jurisdictions across the country that will receive a $470,000 grant from the Justice Department to reopen cold cases using forensic genetic genealogy — a new investigative technique that draws on privately curated DNA databases from popular genealogy websites to compare with samples collected from crimes.
The funding could help investigators reopen as many as 60 cold cases over the next three years, Prince George’s prosecutors and police said at a news conference Thursday.
“This is just another area where we’re going to make a big difference in Prince George’s County,” county State’s Attorney Aisha Braveboy said.
There are more than 600 cases of serious and violent crimes in the county in which DNA was collected from the scene but the sample did not generate a match in the FBI’s Combined DNA Index System, often referred to as CODIS.
The leads ran out, and the cases went cold.
But with this new funding, the county’s cold case task force will be able to spend thousands of dollars reprocessing those DNA samples against data from...
see more
Related Articles
By Darrell Etherington, TechCrunch | 12.29.2020
By Francis S. Collins, M.D., Ph.D., Jennifer A. Doudna, Ph.D., Eric S. Lander, Ph.D., and Charles N. Rotimi, Ph.D., The New England Journal of Medicine | 01.07.2021
The breathtaking progress in molecular genetics that has occurred over the past five decades and the transition to genomic medicine would have been difficult to imagine in 1970, when the Institute of Medicine (IOM), now the National Academy of Medicine...
By Megan Molteni , Wired | 12.30.2020
IN 1987, WHEN researchers first used the word genomics to describe the newly developing discipline of mapping DNA, Eric Green had just finished medical school. A few years later, he found himself working on the front lines of the young field’s...
By Jocelyn Kaiser, Science | 12.22.2020
It’s troubling news that gene therapy researchers have long anticipated: A hemophilia patient injected with a virus carrying a therapeutic gene in a clinical trial has developed a liver tumor. The U.S. Food and Drug Administration (FDA) has halted the...
